Suppr超能文献

干细胞疗法在缺血性心肌病大型动物模型中的疗效:系统评价与荟萃分析

Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis.

作者信息

La Mantia Debora, Bernardini Chiara, Zannoni Augusta, Salaroli Roberta, Wang Changzhen, Bencivenni Silvia, Forni Monica

机构信息

Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, 40064 Bologna, Italy.

Health Sciences and Technologies-Interdepartmental Center for Industrial Research (CIRI-SDV), Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

出版信息

Animals (Basel). 2022 Mar 16;12(6):749. doi: 10.3390/ani12060749.

Abstract

Stem-cell therapy provides a promising strategy for patients with ischemic heart disease. In recent years, numerous studies related to this therapeutic approach were performed; however, the results were often heterogeneous and contradictory. For this reason, we conducted a systematic review and meta-analysis of trials, reporting the use of stem-cell treatment against acute or chronic ischemic cardiomyopathies in large animal models with regard to Left Ventricular Ejection Fraction (LVEF). The defined research strategy was applied to the PubMed database to identify relevant studies published from January 2011 to July 2021. A random-effect meta-analysis was performed on LVEF mean data at follow-up between control and stem-cell-treated animals. In order to improve the definition of the effect measure and to analyze the factors that could influence the outcomes, a subgroup comparison was conducted. Sixty-six studies (n = 1183 animals) satisfied our inclusion criteria. Ischemia/reperfusion infarction was performed in 37 studies, and chronic occlusion in 29 studies; moreover, 58 studies were on a pig animal model. The meta-analysis showed that cell therapy increased LVEF by 7.41% (95% Confidence Interval 6.23−8.59%; p < 0.001) at follow-up, with significative heterogeneity and high inconsistency (I2 = 82%, p < 0.001). By subgroup comparison, the follow-up after 31−60 days (p = 0.025), the late cell injection (>7 days, p = 0.005) and the route of cellular delivery by surgical treatment (p < 0.001) were significant predictors of LVEF improvement. This meta-analysis showed that stem-cell therapy may improve heart function in large animal models and that the swine specie is confirmed as a relevant animal model in the cardiovascular field. Due to the significative heterogeneity and high inconsistency, future translational studies should be designed to take into account the evidenced predictors to allow for the reduction of the number of animals used.

摘要

干细胞疗法为缺血性心脏病患者提供了一种有前景的治疗策略。近年来,开展了许多与此治疗方法相关的研究;然而,结果往往参差不齐且相互矛盾。因此,我们对相关试验进行了系统评价和荟萃分析,报告了在大型动物模型中使用干细胞治疗急性或慢性缺血性心肌病对左心室射血分数(LVEF)的影响。将既定的研究策略应用于PubMed数据库,以识别2011年1月至2021年7月发表的相关研究。对对照组和干细胞治疗组动物随访时的LVEF平均数据进行随机效应荟萃分析。为了完善效应指标的定义并分析可能影响结果的因素,进行了亚组比较。66项研究(n = 1183只动物)符合我们的纳入标准。37项研究采用缺血/再灌注梗死模型,29项研究采用慢性闭塞模型;此外,58项研究使用猪动物模型。荟萃分析表明,在随访时细胞治疗使LVEF提高了7.41%(95%置信区间6.23−8.59%;p < 0.001),存在显著异质性和高度不一致性(I2 = 82%,p < 0.001)。通过亚组比较,31−�0天的随访(p = 0.025)、晚期细胞注射(>7天,p = 0.005)以及手术治疗的细胞递送途径(p < 0.001)是LVEF改善的显著预测因素。这项荟萃分析表明,干细胞疗法可能改善大型动物模型的心脏功能,并且猪被确认为心血管领域相关的动物模型。由于存在显著异质性和高度不一致性,未来的转化研究应设计为考虑已证实的预测因素,以减少动物使用数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/8944644/3d8ceebe4b17/animals-12-00749-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验